NASDAQ: DXCM: Kessler Topaz Meltzer & Check, LLP notifies investors of a securities class action lawsuit filed against DexCom, Inc.

You can also contact a lawyer Jonathan Naji, Esq. by calling (484) 270-1453 or by email at [email protected].

ALLEGED MISCONDUCT OF THE SUSPECTS:
The complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) DexCom’s communications regarding growth and expected margins were unreasonably optimistic due to its dependence on attracting new customers; (2) DexCom was struggling to maintain successful existing distribution channels; and (3) as a result, defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

THE MAIN PLAINTIFF PROCESS:
DexCom investors can, no later than October 21, 2024, seek appointment as a class representative as lead plaintiff through Kessler Topaz Meltzer & Check, LLP or another attorney, or may elect to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. The lead plaintiff is typically the investor or small group of investors with the largest financial interest and who is also adequate and typical of the proposed class of investors. The lead plaintiff selects counsel to represent the lead plaintiff and the class, and such counsel, if approved by the Court, will be lead or class counsel. Your ability to share in any recovery will not be affected by the decision to serve as lead plaintiff or not.

Kessler Topaz Meltzer & Check, LLP encourages DexCom investors who have suffered significant losses to contact the company directly for more information.

CLICK HERE REGISTER FOR THE CASE OR GO TO: https://www.ktmc.com/new-cases/dexcom-inc?utm_source=PR&utm_medium…

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts across the country and around the world. The firm has built a worldwide reputation for excellence and has recovered billions of dollars for victims of fraud and other corporate misconduct. All of our work is driven by a common purpose: protecting investors, consumers, employees and others from fraud, abuse, misconduct and negligence by corporations and fiduciaries. The complaint in this case was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP, please visit www.ktmc.com.

May be considered attorney advertising in certain jurisdictions. Past performance is not a guarantee of future results.

View the source version on businesswire.com: https://www.businesswire.com/news/home/20240823019587/en/

Dexcom shares at the time of the news release rose by +0.58 % to 65.46EUR on the Tradegate exchange (August 23, 2024, 4:58 PM).

Diskutieren Sie über die entaltenen Werte